BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24219812)

  • 1. Loss of melanocytes in hypopigmented mycosis fungoides: a study of 18 patients.
    Furlan FC; de Paula Pereira BA; da Silva LF; Sanches JA
    J Cutan Pathol; 2014 Feb; 41(2):101-7. PubMed ID: 24219812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo.
    Singh ZN; Tretiakova MS; Shea CR; Petronic-Rosic VM
    Mod Pathol; 2006 Sep; 19(9):1255-60. PubMed ID: 16778827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
    Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
    Furlan FC; Pereira BA; Sotto MN; Sanches JA
    Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides.
    Magro CM; Hagen JW; Crowson AN; Liu YC; Mihm M; Drucker NM; Yassin AH
    J Dermatol; 2014 Jul; 41(7):609-17. PubMed ID: 24806661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annular hypopigmented mycosis fungoides: a novel ringed variant.
    Uhlenhake EE; Mehregan DM
    J Cutan Pathol; 2012 May; 39(5):535-9. PubMed ID: 22515225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study.
    Castano E; Glick S; Wolgast L; Naeem R; Sunkara J; Elston D; Jacobson M
    J Cutan Pathol; 2013 Nov; 40(11):924-34. PubMed ID: 24320808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
    El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
    Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic profile of hypopigmented mycosis fungoides in India.
    Koorse S; Tirumalae R; Yeliur IK; Jayaseelan E
    Am J Dermatopathol; 2012 Apr; 34(2):161-4. PubMed ID: 22240772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
    Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
    Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopigmented mycosis fungoides: case reports and literature review.
    Qari MS; Li N; Demierre MF
    J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopigmented mycosis fungoides in an adolescent Turkish boy.
    Gülekon A; Ozsoy E; Gürer MA; Ataoģlu O
    Int J Dermatol; 2005 Sep; 44(9):795-6. PubMed ID: 16135159
    [No Abstract]   [Full Text] [Related]  

  • 17. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Melanocyte Loss in Mycosis Fungoides Using SOX10 Immunohistochemistry.
    Barron CR; Smoller BR
    Dermatopathology (Basel); 2021 Jul; 8(3):277-284. PubMed ID: 34287276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypopigmented Interface T-Cell Dyscrasia and Hypopigmented Mycosis Fungoides: A Comparative Study.
    Youssef R; Mahgoub D; Zeid OA; Abdel-Halim DM; El-Hawary M; Hussein MF; Morcos MA; Aboelfadl DM; Abdelkader HA; Abdel-Galeil Y; Abdel-Halim MRE
    Am J Dermatopathol; 2018 Oct; 40(10):727-735. PubMed ID: 30188378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.